| Epithelial IL-18 equilibrium controls barrier function in colitis R Nowarski, R Jackson, N Gagliani, MR de Zoete, NW Palm, W Bailis, ... Cell 163 (6), 1444-1456, 2015 | 577 | 2015 |
| Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors S Xu, O Chaudhary, P Rodríguez-Morales, X Sun, D Chen, R Zappasodi, ... Immunity 54 (7), 1561-1577. e7, 2021 | 455 | 2021 |
| Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto*, MM Sauer*, N Czudnochowski*, JS Low*, MA Tortorici, ... Science 373 (6559), 1109-1116, 2021 | 346 | 2021 |
| Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity A Jarret, R Jackson, C Duizer, ME Healy, J Zhao, JM Rone, P Bielecki, ... Cell 180 (1), 50-63. e12, 2020 | 194 | 2020 |
| Differential roles of IL-2 signaling in developing versus mature Tregs MY Fan, JS Low, N Tanimine, KK Finn, B Priyadharshini, SK Germana, ... Cell reports 25 (5), 1204-1213. e4, 2018 | 160 | 2018 |
| Effector TH17 cells give rise to long-lived TRM cells that are essential for an immediate response against bacterial infection MCA Vesely, P Pallis, P Bielecki, JS Low, J Zhao, CCD Harman, ... Cell 178 (5), 1176-1188. e15, 2019 | 154 | 2019 |
| Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 JS Low*, D Vaqueirinho*, F Mele*, M Foglierini, J Jerak, M Perotti, ... Science 372 (6548), 1336-1341, 2021 | 143 | 2021 |
| ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... Science 377 (6607), 735-742, 2022 | 129 | 2022 |
| Heat shock protein 90 controls HIV-1 reactivation from latency I Anderson, JS Low, S Weston, M Weinberger, A Zhyvoloup, AA Labokha, ... Proceedings of the National Academy of Sciences 111 (15), E1528-E1537, 2014 | 125 | 2014 |
| Tissue-resident memory T cell reactivation by diverse antigen-presenting cells imparts distinct functional responses JS Low, Y Farsakoglu, MC Amezcua Vesely, E Sefik, JB Kelly, ... Journal of Experimental Medicine 217 (8), 2020 | 118 | 2020 |
| Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response FV Pereira, ACL Melo, JS Low, ÍA de Castro, TT Braga, DC Almeida, ... Oncotarget 9 (40), 25808, 2018 | 86 | 2018 |
| SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines JE Bowen, YJ Park, C Stewart, JT Brown, WK Sharkey, AC Walls, A Joshi, ... Science Immunology 7 (78), eadf1421, 2022 | 57 | 2022 |
| Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22 AD Giannou, J Kempski, AM Shiri, J Lücke, T Zhang, L Zhao, DE Zazara, ... Immunity 56 (1), 125-142. e12, 2023 | 40 | 2023 |
| Hsp90: a chaperone for HIV-1 JS Low, A Fassati Parasitology 141 (9), 1192-1202, 2014 | 19 | 2014 |
| Novel trends of genome evolution in highly complex tropical sponge microbiomes JB Kelly, DE Carlson, JS Low, RW Thacker Microbiome 10 (1), 164, 2022 | 13 | 2022 |
| A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... bioRxiv, 2021.05. 09.442808, 2021 | 13 | 2021 |
| The Relationship Between Microbiomes and Selective Regimes in the Sponge Genus Ircinia JB Kelly, DE Carlson, JS Low, T Rice, RW Thacker Frontiers in Microbiology 12, 607289, 2021 | 12 | 2021 |
| Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape R Marzi, J Bassi, C Silacci-Fregni, I Bartha, F Muoio, K Culap, ... Iscience 26 (1), 2023 | 10 | 2023 |
| SMAD4 and TGFβ are architects of inverse genetic programs during fate determination of antiviral CTLs K Chandiran, JE Suarez-Ramirez, Y Hu, ER Jellison, Z Ugur, JS Low, ... Elife 11, e76457, 2022 | 8 | 2022 |
| ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... bioRxiv, 2022.03. 30.486377, 2022 | 8 | 2022 |